Abstract
Static primary cultures of bovine anterior pituitary (AP) cells were utilized to study the effect of sex steroids on basal growth hormone (GH) and GH-releasing hormone (GRF)-stimulated release of GH. The AP cells (5 × 10 5 cells/well) were allowed to attach for 72 hr and become confluent before treatments were imposed. Cells were incubated for an additional 24, 48 or 72 hr with either estradiol-17β (E 2, 10 −11 to 10 −8 M), testosterone (T, 10 −8 to 10 −5 M), dihydrotestosterone (DHT, 10 −9 to 10 −6 M) or 5α-androstane-3α, 17β-diol (3α-diol, 10 −11 to 10 −8 M). Media were collected every 24 hr and GH concentrations determined by RIA. Incubation of calf AP cells with gonadal steroids did not affect (P>0.05) basal GH released at 24, 48, or 72 hr. In another experiment, calf AP cells were incubated with the same concentrations of the steroids for 24 hr, media harvested, cells washed and challenged in serum-free media for 1 hr with bovine GRF 1–44-NH 2 (10 −8 M). In non-steroid treated wells, GRF increased (P<0.05) GH from 58 to 134 ng/ml. Incubation with E 2 or 3α-diol did not affect (P>0.05) GRF-induced GH release; however, preincubation with T (10 −5 M) and DHT (10 −9, 10 −8 and 10 −7 M) increased (P<0.05) GRF-induced GH release above control concentrations (195, 235, 190 and 185 ng/ml, respectively). At the doses tested, sex steroids did not affect basal release of GH, but androgens increased responsiveness of somatotropes to GRF.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.